Dr. McClure’s main research interest is understanding the genetics underlying leukemias and lymphomas. She spent much of her time at Mayo Clinic in the area of translational research, which involves dealing with the difficult, practical issues of transferring basic research findings into orderable clinical tests. In her capacity as the director of a large molecular testing laboratory, she was an early adopter of high-throughput sequencing technology for clinical test development. This powerful, new technology is rapidly changing the way medicine is practiced, as it allows physicians to rapidly, and cost-effectively, obtain large amounts of genetic information that has not been available in the past. Because abnormal genetic processes are responsible for a wide variety of disorders including cancers, inherited disorders and infectious diseases, the new technology has many applications in both the clinical setting and in research laboratories studying the genetics of these diseases.